INDRAPRASTHA MEDICAL CORPORATION Financial Statement Analysis
|
||
|
The Revenues of INDRAPRASTHA MEDICAL CORPORATION have increased by 44.80% YoY .
The Earnings Per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION has increased by 47.10 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
INDRAPRASTHA MEDICAL CORPORATION Last 5 Annual Financial Results
[BOM: 532150|NSE : INDRAMEDCO]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Operating Income | ₹888 Cr | ₹613 Cr | ₹8,308 Cr | ₹788 Cr | ₹753 Cr |
| Expenses | ₹774 Cr | ₹573 Cr | ₹7,444 Cr | ₹707 Cr | ₹680 Cr |
| Operating Profit (Excl OI) | ₹114 Cr | ₹40 Cr | ₹864 Cr | ₹81 Cr | ₹73 Cr |
| Other Income | ₹3.12 Cr | ₹0.68 Cr | ₹6.87 Cr | ₹0.47 Cr | ₹0.79 Cr |
| Interest | ₹3.41 Cr | ₹3.34 Cr | ₹59 Cr | ₹6.87 Cr | ₹8.90 Cr |
| Depreciation | ₹35 Cr | ₹33 Cr | ₹330 Cr | ₹30 Cr | ₹31 Cr |
| Profit Before Tax | ₹79 Cr | ₹4.29 Cr | ₹482 Cr | ₹45 Cr | ₹34 Cr |
| Consolidated Net Profit | ₹59 Cr | ₹2.33 Cr | ₹436 Cr | ₹28 Cr | ₹21 Cr |
| Earnings Per Share (Rs) | ₹9.40 | ₹6.39 | ₹0.25 | ₹4.76 | ₹3.10 |
| PAT Margin (%) | 7.84 | 6.60 | 0.38 | 5.25 | 3.60 |
| ROE(%) | 24.44 | 19.60 | 0.86 | 17.05 | 11.93 |
| ROCE(%) | 34.46 | 27.58 | 2.80 | 20.15 | 18.29 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.01 | 0.09 |
Key Financials |
||
| Market Cap | : | ₹ 2,191.6 Cr |
| Revenue (TTM) | : | ₹ 1,204.0 Cr |
| Net Profit(TTM) | : | ₹ 112.6 Cr |
| EPS (TTM) | : | ₹ 12.3 |
| P/E (TTM) | : | 19.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDRAPRASTHA MEDICAL CORPORATION | 1.3% | -12.3% | 124.7% |
| APOLLO HOSPITALS ENTERPRISE | 3.4% | -6.6% | 49% |
| MAX HEALTHCARE INSTITUTE | 5.7% | -8.7% | 59.1% |
| GLOBAL HEALTH | 6.7% | -13.1% | 164.4% |
| FORTIS HEALTHCARE | 2.6% | -6.4% | 59.4% |
| NARAYANA HRUDAYALAYA | 2% | -9.6% | 59.5% |
| ASTER DM HEALTHCARE | 1.9% | -6.1% | 86.2% |
| DR LAL PATHLABS | 12.9% | -7.3% | 19.6% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 3.3% | -8.3% | 51.4% |
INDRAPRASTHA MEDICAL CORPORATION Revenues
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 44.80 % |
| 5 Yr CAGR | 4.23 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹888 Cr | 44.80 | |
| Mar2022 | ₹613 Cr | -92.62 | |
| Mar2021 | ₹8,308 Cr | 954.04 | |
| Mar2020 | ₹788 Cr | 4.72 | |
| Mar2019 | ₹753 Cr | - | |
INDRAPRASTHA MEDICAL CORPORATION Operating Profit
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 183.83 % |
| 5 Yr CAGR | 11.94 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹114 Cr | 183.83 | |
| Mar2022 | ₹40 Cr | -95.34 | |
| Mar2021 | ₹864 Cr | 969.47 | |
| Mar2020 | ₹81 Cr | 10.97 | |
| Mar2019 | ₹73 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 95.89 % |
| 5 Yr CAGR | 7.41 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 12.87% | 95.89 | |
| Mar2022 | 6.57% | -36.83 | |
| Mar2021 | 10.4% | 1.46 | |
| Mar2020 | 10.25% | 6.00 | |
| Mar2019 | 9.67% | - | |
INDRAPRASTHA MEDICAL CORPORATION Profit After Tax
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 2,415.88 % |
| 5 Yr CAGR | 29.10 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹59 Cr | 2,415.88 | |
| Mar2022 | ₹2.33 Cr | -99.47 | |
| Mar2021 | ₹436 Cr | 1,435.35 | |
| Mar2020 | ₹28 Cr | 34.64 | |
| Mar2019 | ₹21 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 18.79 % |
| 5 Yr CAGR | 21.48 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 7.84 % | 18.79 | |
| Mar2022 | 6.6 % | 1,636.84 | |
| Mar2021 | 0.38 % | -92.76 | |
| Mar2020 | 5.25 % | 45.83 | |
| Mar2019 | 3.6 % | - | |
INDRAPRASTHA MEDICAL CORPORATION Earnings Per Share (EPS)
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 47.10 % |
| 5 Yr CAGR | 31.96 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹9.40 | 47.10 | |
| Mar2022 | ₹6.39 | 2,456.00 | |
| Mar2021 | ₹0.25 | -94.75 | |
| Mar2020 | ₹4.76 | 53.55 | |
| Mar2019 | ₹3.10 | - | |
INDRAPRASTHA MEDICAL CORPORATION Return on Capital Employed (ROCE)
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 24.95 % |
| 5 Yr CAGR | 17.16 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 34.46% | 24.95 | |
| Mar2022 | 27.58% | 885.00 | |
| Mar2021 | 2.8% | -86.10 | |
| Mar2020 | 20.15% | 10.17 | |
| Mar2019 | 18.29% | - | |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
| Current Share Price | : | ₹239.0 |
| Current MarketCap | : | ₹ 2,191.6 Cr |
| Updated EOD on | : | Apr 18,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAPRASTHA MEDICAL CORPORATION | 1.3% |
-12.3% |
124.7% |
| SENSEX | -2.9% |
-0.4% |
20% |
INDRAPRASTHA MEDICAL CORPORATION related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | -1.1% | 11.8% | 62% |
| S&P BSE MIDSMALLCAP | -1.2% | 9.4% | 62.3% |
| S&P BSE ALLCAP | -2.2% | 3.9% | 37% |
| S&P BSE HEALTHCARE | -3.1% | 2.5% | 51.1% |
No NSE index found
You may also like the below Video Courses
FAQ about INDRAPRASTHA MEDICAL CORPORATION Financials
How the annual revenues of INDRAPRASTHA MEDICAL CORPORATION have changed ?
The Revenues of INDRAPRASTHA MEDICAL CORPORATION have increased by 44.80% YoY .
How the Earnings per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION have changed?
The Earnings Per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION has increased by 47.10 % YoY .
Check out Intrinsic Value of Peers of INDRAPRASTHA MEDICAL CORPORATION
Compare Stock Analytics of Peers of INDRAPRASTHA MEDICAL CORPORATION
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
